C. Polizzi

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

C. Anderson, A. Baron, D. Parkes, 2010, Cardiovascular diabetology.

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

C. Anderson, A. Baron, D. Parkes, 2010, Cardiovascular diabetology.

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.

B. Gedulin, D. Parkes, D. Hargrove, 2010, American journal of physiology. Endocrinology and metabolism.

Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.

D. Parkes, K. Tatarkiewicz, C. Villescaz, 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer

A. Mercurio, H. Goel, L. Nangle, 2023, Science Translational Medicine.

Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation

E. Crouser, L. Nangle, S. Paz, 2021, Sarcoidosis and other granulomatous ILD / DPLD.

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

C. Anderson, A. Baron, D. Parkes, 2010, Cardiovascular diabetology.